flumazenil has been researched along with Arterial Brain Diseases in 1 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chida, K | 1 |
| Ogasawara, K | 1 |
| Kuroda, H | 1 |
| Aso, K | 1 |
| Kobayashi, M | 1 |
| Fujiwara, S | 1 |
| Yoshida, K | 1 |
| Terasaki, K | 1 |
| Ogawa, A | 1 |
1 other study available for flumazenil and Arterial Brain Diseases
| Article | Year |
|---|---|
Central benzodiazepine receptor binding potential and CBF images on SPECT correlate with oxygen extraction fraction images on PET in the cerebral cortex with unilateral major cerebral artery occlusive disease.
Topics: Adult; Aged; Arterial Occlusive Diseases; Basal Ganglia; Carotid Stenosis; Cerebellum; Cerebral Cort | 2011 |